Who owns the ASGARD THERAPEUTICS trademark?

The ASGARD THERAPEUTICS trademark is owned by Asgard Therapeutics AB.

What class is the ASGARD THERAPEUTICS trademark registered in?

The ASGARD THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ASGARD THERAPEUTICS?

The USPTO serial number for ASGARD THERAPEUTICS is 79357230.

What is the registration number for ASGARD THERAPEUTICS?

ASGARD THERAPEUTICS is registered under USPTO registration number 7333962.

ASG

USPTO Trademark Record

REGISTERED

ASGARD THERAPEUTICS

SN 79357230·Reg 7333962·Filed Nov 14, 2022

Owner Asgard Therapeutics AB

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ASGARD THERAPEUTICS (Serial No. 79357230), Registration No. 7333962, is a registered US trademark filed on Nov 14, 2022 by Asgard Therapeutics AB. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: March 26, 2030

Mark Intelligence

ASGARD THERAPEUTICS (Reg. #7333962) is a registered US trademark that has been protecting its owner, Asgard Therapeutics AB, since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Nov 14, 2022

SERIAL

79357230

REG#

7333962

REGISTERED

Mar 26, 2024

Owner

Applicant

Asgard Therapeutics AB

Entity

AB (Swedish)

Address

Medicon Village, SE-223 81 Lund

Country

Attorney

NameJoseph R. Dages

Law firm

Joseph R. Dages Gray Ice Higdon, PLLC

Docket

ASGA-0002

Address

3939 Shelbyville Road, Suite 201, Louisville, KY 40207, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateNov 14, 2022

Serial Number79357230

Registration No.7333962

Registration DateMar 26, 2024

Status DateMar 26, 2024

Published for OppositionJan 09, 2024

Mark TypeStandard characters

Attorney DocketASGA-0002

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

25 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Nov 09, 2024

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION NOTICE SENT TO IB

Oct 17, 2024

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION PROCESSED

Oct 16, 2024

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 27, 2024

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Mar 26, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 26, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jan 09, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 09, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Jan 08, 2024

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 20, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Dec 20, 2023

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Dec 20, 2023

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 01, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 06, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 06, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 06, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Oct 10, 2023

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Sep 18, 2023

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Sep 18, 2023

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Aug 29, 2023

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

ASSIGNED TO EXAMINER

Aug 28, 2023

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Aug 28, 2023

NON-FINAL ACTION WRITTEN

APPLICATION FILING RECEIPT MAILED

Dec 13, 2022

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 09, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Dec 08, 2022

SN ASSIGNED FOR SECT 66A APPL FROM IB

ASGARD THERAPEUTICS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Joseph R. Dages

Industries

USPTO Deadlines

Compare

Resources

Company